Antiviral Clinical Trial for Long Covid-19
Phase 2
90
about 1.3 years
18+
1 site in NY
About this study
This trial is testing if two repurposed HIV antivirals can reduce symptom burden in adults with Long Covid compared to placebo. Participants will be randomly assigned to receive antivirals, Truvada (tenofovir disoproxil/emtricitabine), Selzentry, or a placebo taken daily for 90 days.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Placebo
- 2.Take Selzentry
- 3.Take tenofovir disoproxil/emtricitabine
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
emtricitabine, tenofovir disoproxil
oral (Oral Capsule)
Primary: EuroQol 5-Dimension 5-Level (EQ-5D-5L) Visual Analogue Scale
Secondary: Composite Autonomic Symptom Score 31(COMPASS-31), Fatigue Severity Scale (FSS), Fatigue Visual Analogue Scale (F-VAS), General Symptom Questionnaire (GSQ-30), Generalized Anxiety Disorder (GAD-7), Neuro-QoL™ v2.0 Cognitive Function-Short Form, Pain Visual Analogue Scale (P-VAS), Patient Health Questionnaire (PHQ-9)